i

insitro

228 employees

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
drug development
Pharmaceutical
machine learning
Machine Learning
Health Care
data science
Therapeutics
science
life science
Life Science
biotech

Date founded

2018

Funding rounds raised

Total raised

$400M

from 30 investors over 30 rounds

i

insitro raised $400M on March 15, 2021

Investors: Third Rock Ventures, GV, SoftBank Investment Advisers, Two Sigma Ventures, Casdin Capital, LLC, Temasek, Foresite Capital, T. Rowe Price and HOF Capital

i

insitro raised $143M on May 26, 2020

Investors: Casdin Capital, LLC, GV, T. Rowe Price, Two Sigma Ventures, Foresite Capital, HOF Capital, Third Rock Ventures and WuXi AppTec

i

insitro raised $100M on April 16, 2019

Investors: Bezos Expeditions, GV, ARCH Venture Partners, Two Sigma Ventures, Third Rock Ventures and Foresite Capital

i

insitro raised $100M on May 2, 2018

Investors: Bezos Expeditions, Foresite Capital, GV, Verily, Andreessen Horowitz, ARCH Venture Partners and Two Sigma Ventures

FAQ